Lol thanks Kate,
I think this has everything to do with Big Pharmas closing up on R&D & acquiring more advanced biotech for their pipelines, instead of spending billions for research from scratch. Also the US tax rebate...billions offshore, that can be beneficial to AU smaller biotechs...I cannot say anything for VRL...except that DXB have put us in the perfect position for a T/O, even though it’s been a bit tough with negativity, to me everything has seemed to be timed well. I would expect a 1.5b Deal for what DXB have at least.
That’s my opinion. Their patents will verify that. Best wishes
Add to My Watchlist
What is My Watchlist?
. Best wishes 